Recent findings from a follow-up study on a small group of patients who received an experimental mRNA treatment for pancreatic cancer show very promising results Nearly 90% of people whose immune systems responded to the vaccine were still alive up to six years after receiving the last treatment. As of now, the five-year survival rate for pancreatic cancer patients is just 13%. Vassy Kapelos speaks with Dr. Isaac Bogoch.